RT Journal Article
SR Electronic
T1 Characterizing genetic profiles for high triglyceride levels in U.S. patients of African ancestry
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.03.11.24304107
DO 10.1101/2024.03.11.24304107
A1 Jiang, Lan
A1 Gangireddy, Srushti
A1 Dickson, Alyson L.
A1 Kawai, Vivian
A1 Cox, Nancy J.
A1 Linton, MacRae F.
A1 Wei, Wei-Qi
A1 Stein, C. Michael
A1 Feng, QiPing
YR 2024
UL http://medrxiv.org/content/early/2024/03/13/2024.03.11.24304107.abstract
AB Hypertriglyceridemia (HTG) is a common cardiovascular risk factor characterized by elevated circulating triglyceride (TG) levels. Researchers have assessed the genetic factors that influence HTG in studies focused predominantly on individuals of European ancestry (EA). However, relatively little is known about the contribution of genetic variation to HTG in people of AA, potentially constraining research and treatment opportunities; the lipid profile for African ancestry (AA) populations differs from that of EA populations—which may be partially attributable to genetics. Our objective was to characterize genetic profiles among individuals of AA with mild-to-moderate HTG and severe HTG versus those with normal TGs by leveraging whole genome sequencing (WGS) data and longitudinal electronic health records (EHRs) available in the All of Us (AoU) program. We compared the enrichment of functional variants within five canonical TG metabolism genes, an AA-specific polygenic risk score for TGs, and frequencies of 145 known potentially causal TG variants between patients with HTG and normal TG among a cohort of AA patients (N=15,373). Those with mild-to-moderate HTG (N=342) and severe HTG (N≤20) were more likely to carry APOA5 p.S19W (OR=2.21, 95% CI [1.70-2.88], p=2.74×10-9 and OR=4.16, 95% CI [1.39-12.45], p=0.01, respectively) than those with normal TG. They were also more likely to have an elevated (top 10%) PRS, elevated carriage of potentially causal variant alleles, and carry any genetic risk factor. Alternative definitions of HTG yielded comparable results. In conclusion, individuals of AA with HTG were enriched for genetic risk factors compared to individuals with normal TGs.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was supported by GM120523 (Q.F.), R01HL163854 (Q.F.), HL133786 (W.Q.W.), and Vanderbilt Faculty Research Scholar Fund (Q.F.). Role of the Funder/Sponsor: The funders had no role in design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced are available online at All of Us (AoU)